Medicines for Europe welcomes decision on EMA relocation to Amsterdam

21 November 2017

Medicines for Europe is very glad to see the Council […]

Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine costs

18 October 2017

On Thursday 12 October, the Directorate-general for Internal Market, Industry, […]

Medicines for Europe announces new President, launches Access to Medicines campaign

10 October 2017

The newly elected President of Medicines for Europe – Marc-Alexander Mahl – […]

Addressing medicine shortages in Europe: Competition is crucial for patient access

29 September 2017

Generic medicines have proven to be pivotal in increasing patient […]

62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

15 June 2017

Pharmaceutical industry leaders and key stakeholders from the generic, biosimilar […]

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

The European Semester Country Specific Recommendations show that healthcare systems […]

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access

Newsroom

News about

By type

Twitter

Videos

Photos

Medicines for Europe welcomes decision on EMA relocation to Amsterdam

21 November 2017

Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine costs

18 October 2017

Medicines for Europe announces new President, launches Access to Medicines campaign

10 October 2017

Addressing medicine shortages in Europe: Competition is crucial for patient access

29 September 2017

62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

15 June 2017

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

European Parliament Recognises the Major role of Generic, Biosimilar and Value Added Medicines in Improving Access

2 March 2017

Joint Declaration for an ambitious EU industrial strategy

27 February 2017

Subscribe to our newsletter

Share on Mastodon